Ursula Matulonis, MD
Dana-Farber Cancer Institute
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Ursula Matulonis, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 23:56 UTC. Open this list on ClinicalTrials.gov
- Ph3NCT04296890 · A Study of Mirvetuximab Soravtansine in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha ExpressionImmunoGen, Inc. · completed · Epithelial Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer · principal investigator
- Ph1/Ph2NCT02915523 · Study of Avelumab With or Without Entinostat in Participants With Advanced Epithelial Ovarian CancerSyndax Pharmaceuticals · completed · Epithelial Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer · principal investigator
- Ph2NCT02865811 · Pembrolizumab Combined With PLD For Recurrent Platinum Resistant Ovarian, Fallopian Tube Or Peritoneal CancerDana-Farber Cancer Institute · completed · Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer · principal investigator
- Ph2NCT00856180 · Sequential Angiogenic Blockade for the Treatment of Recurrent Mullerian MalignanciesDana-Farber Cancer Institute · completed · Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer · principal investigator
- Ph2NCT00322881 · Carboplatin and Paclitaxel in Elderly Women With Newly Diagnosed Ovarian, Peritoneal, or Fallopian CancerDana-Farber Cancer Institute · terminated · Ovarian Cancer, Primary Peritoneal Carcinoma, Fallopian Tube Cancer · principal investigator
- Ph2NCT00230542 · Carboplatin and Pemetrexed in Recurrent Platinum Sensitive Ovarian CancerDana-Farber Cancer Institute · completed · Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-11 23:56 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 23:56 UTC. The ranking covers the 200 most relevant of 2 PubMed records, and a shared surname and initials can bring in a namesake. All 2 on PubMed
- Transplantation Outcomes with Donor Hearts after Circulatory Death.N Engl J Med · 2023301 citationsRCR 41.0
- Besifovir Dipivoxil Maleate 144-Week Treatment of Chronic Hepatitis B: An Open-Label Extensional Study of a Phase 3 Trial.Am J Gastroenterol · 202020 citationsRCR 1.1